Taysha Gene Therapies, Inc. (TSHA)
4.005
-0.06
(-1.35%)
USD |
NASDAQ |
Nov 17, 16:00
4.005
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Price to Book Value : 3.656 for Nov. 17, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 3.706 |
| November 13, 2026 | 3.743 |
| November 12, 2026 | 3.843 |
| November 11, 2026 | 3.907 |
| November 10, 2026 | 3.903 |
| November 09, 2026 | 3.989 |
| November 06, 2026 | 3.953 |
| November 05, 2026 | 3.734 |
| November 04, 2026 | 3.980 |
| November 03, 2026 | 3.734 |
| November 02, 2026 | 3.652 |
| October 30, 2026 | 3.770 |
| October 29, 2026 | 3.852 |
| October 28, 2026 | 3.862 |
| October 27, 2026 | 3.880 |
| October 26, 2026 | 3.661 |
| October 23, 2026 | 3.615 |
| October 22, 2026 | 3.656 |
| October 21, 2026 | 3.761 |
| October 20, 2026 | 3.752 |
| October 19, 2026 | 3.597 |
| October 16, 2026 | 3.305 |
| October 15, 2026 | 3.405 |
| October 14, 2026 | 3.204 |
| October 13, 2026 | 3.268 |
| Date | Value |
|---|---|
| October 12, 2026 | 3.779 |
| October 09, 2026 | 4.099 |
| October 08, 2026 | 4.044 |
| October 07, 2026 | 4.044 |
| October 06, 2026 | 4.008 |
| October 05, 2026 | 4.099 |
| October 02, 2026 | 4.227 |
| October 01, 2026 | 4.327 |
| September 30, 2026 | 4.446 |
| September 29, 2026 | 4.192 |
| September 28, 2026 | 4.192 |
| September 25, 2026 | 3.923 |
| September 24, 2026 | 4.024 |
| September 23, 2026 | 4.124 |
| September 22, 2026 | 4.334 |
| September 21, 2026 | 4.234 |
| September 18, 2026 | 4.217 |
| September 17, 2026 | 4.334 |
| September 16, 2026 | 4.259 |
| September 15, 2026 | 4.250 |
| September 14, 2026 | 4.208 |
| September 11, 2026 | 4.217 |
| September 10, 2026 | 4.334 |
| September 09, 2026 | 4.486 |
| September 08, 2026 | 4.603 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Imunon, Inc. | 1.460 |
| Altimmune, Inc. | 0.6732 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.26 |
| Anika Therapeutics, Inc. | 1.255 |
Price to Book Value Related Metrics
| PS Ratio | 260.46 |
| PEG Ratio | -0.3978 |
| Price | 4.005 |
| Earnings Yield | -10.89% |
| Market Cap | 1.305B |
| PEGY Ratio | -0.3978 |